Aligos Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

앨리고스 테라퓨틱스NASDAQ:ALGS · Nasdaq · Healthcare

$5.54+0.73%

2026-10-02 close

Aligos Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $4M. 2024 operating profit was −$89M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy